Showing posts with label biotech. Show all posts
Showing posts with label biotech. Show all posts

AI & Biotech: Striking a Technological Balance of Power

November 26, 2016 (Tony Cartalucci - LocalOrg) - During World War 2, nations desperately raced to harness the atom. The United State ultimately won that race, and during their victory lap - being the sole nation to possess nuclear weapons - used them against their enemy Japan - twice.

Tens of thousands of lives were extinguished in the blink of an eye and Japan, already a defeated nation, submitted absolutely to US hegemony which would prevail both over Japan and most of Asia for nearly a century onward.

Images: The atomic bombing of Hiroshima and Nagasaki. This is what uncontested military superiority - or an imbalance of technological and military power - looks like. What will similar disparity in artificial intelligence or biotechnology lead to? 

Since the bombings of Hiroshima and Nagasaki, the US has used its immense economic disparity over the last seven decades to build a conventional army and employ various methods of overtly and covertly attacking, undermining, and even overthrowing the political and socioeconomic orders of targeted nations worldwide in its bid to take, hold, and expand global hegemony.

It has used its domination of the media to sell wars, manipulate public perception, and project its socioeconomic, cultural, and military will to the far reaches of the planet.

With the advent of the Internet and social media, its domination over both allowed it to plunge the entire Middle East and North Africa (MENA) into chaos and eventually war in 2011 during the so-called "Arab Spring," a fact the New York Times in an article titled, "U.S. Groups Helped Nurture Arab Uprisings," would later admit.

Balancing Power 

With each form of tactical and technological disparity manifesting itself in military aggression, subjugation, exploitation, and immeasurable injustice, attempts to diminish that disparity have helped strike a balance of power.

Image: Russian mobile nuclear missiles and the reason why the United States never used nuclear weapons again.

The development of nuclear weapons by the Soviets, then later China, India, and Pakistan as well as several European powers, helped strike a balance of power within which no nation dared strike another with such weapons again.

Asymmetrical warfare and increasingly sophisticated and prolific anti-tank and anti-air weaponry have allowed nations to raise the cost of US military adventures abroad to the point where direct military intervention has become all but impossible for the US (and other nations as well).

The alternative media has brought to an end what was almost total domination by the Western media over global public perception - and it has done so not only with the emergence of effective state-run media beyond the West, but also through the efforts of thousands of individuals and independent networks worldwide.

Liz Parrish - Bioviva - Ending Ageing through Gene Therapy

February 5, 2016 (LocalOrg) - Agree or disagree with her methods, Liz Parrish and her company, Bioviva are taking gene therapy into their own hands in an attempt to circumvent the corrupt pharmaceutical monopolies, their representatives in the media and government, and shift the paradigm toward a more decentralized means of research and development.

Big-Pharma Seeks Monopoly Over Life-Changing Therapy

By dangling life-changing cures over people's heads for cartoonish figures of "1 million dollars," pharmaceutical corporations prove when they see sick, desperate, dying people, all they see is dollar signs... 

November 12, 2015 (Tony Cartalucci - LocalOrg) - Gene therapy is a game changer. It is not a treatment for diseases. It is a cure.

Image: Gene therapy works by reprogramming an ordinary virus to delivery modified genes to human cells. Once introduced, the modified genes are replicated by natural cell division. Missing or defective genes, over time, can be replaced by repaired genes, reprogramming the immune system to eradicate otherwise incurable diseases, or creating function in defective systems, curing blindness, deafness, diabetes, and even effects owed to aging. 

It is a cure for cancer, genetic defects, blindness, deafness, diabetes, even potentially aging.

It has already proven effective in clinical trials, curing people of leukemia who were otherwise certain to die, giving people their sight back, and already, there is one therapy approved for use in the European Union with several others approved in China.

The most remarkable aspect of gene therapy is that it overwrites your DNA once, then your cells replicate that new DNA each time they divide. In essence, the cure becomes a permanent part of you. One shot, one cure, for life, or close to it.

Why Haven't We Heard More About This? 

As remarkable and as promising as gene therapy is, it poses an immense threat to the established healthcare industry. A shot in clinical trials using experimental equipment that costs only 20,000 USD to produce that cures leukemia, if brought into mainstream medicine would be cheaper still, and undercut existing and ineffective"treatments" that can reach costs in the hundreds of thousands of dollars.

Gene therapy, then, is essentially a disruptive technology that brings various healthcare rackets to an abrupt halt along with all the vast wealth and unwarranted power and influence big-pharma has enjoyed over the decades.

Image: Dr. Carl June (center) led a team that developed a breakthrough gene therapy that effectively reprograms the immune system to hunt and kill leukemia cancer cells. Most of the patients, otherwise sure to die from their cancer, have gone into permanent remission. 

How can big-pharma continue on with its monopolies, wealth, and influence by curing everyone with one shot that costs almost nothing to make?

Their strategy is two-fold. First, they have intentionally dragged their feet for as long as possible until they can figure this problem out, letting people die of now curable diseases simply because they want to protect their existing business models and bottom lines.

Second, they have begun to mold public opinion through intense lobbying across the media and medical journals, ignoring the actual costs involved in producing the therapies, and instead cashing in on what they think it is worth to people, or in other words, dangling cures for crippling, deadly diseases over dying and/or desperate people's heads, and seeing how much they are willing to pay for them.